AZ antibiotic receives positive CHMP opinion

Friday 22 June 2012

An antibiotic from AstraZeneca Plc is one of four new medicines to be recommended for marketing in Europe by the EMA’s Committee for Medicinal Products for Human Use. The drug, Zinforo, is a cephalosporin antibiotic.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom